Cholangiocarcinoma
Cancer of the bile ducts. Subtyped by location (intrahepatic, perihilar, distal). Increasingly treated with targeted therapy for FGFR2 fusions and IDH1 mutations.
1 Conditions
Cancer of the bile ducts. Subtyped by location (intrahepatic, perihilar, distal). Increasingly treated with targeted therapy for FGFR2 fusions and IDH1 mutations.
1 Conditions